ArticleNeurochemical research2026
A Primary Spinal Cord Mixed Culture Method for In Vitro Analysis of Glial Heterogeneity and Inflammatory Responses.
Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditional in vitro models used in spinal cord research often rely on simplified cell systems, such as PC-12 cells, which do not reproduce the mixed cellular environment or glia-neuron interactions of spinal cord tissue. Although primary spinal cord cultures have been described, many protocols focus on purified populations and require technically demanding or costly procedures. In this study, we established a low-cost mixed primary spinal cord culture from neonatal Wistar rats and characterized its cellular composition and inflammatory responsiveness in vitro. At 7 days in vitro, immunofluorescence analysis showed the presence of neurons (42.5%), astrocytes (17.2%), and microglia (4.4%), together with an unresolved non-labeled cell population (35.9%). GFAP-positive astrocytes displayed marked morphological heterogeneity, including process-bearing, flattened, and ramified forms. To examine the inflammatory responsiveness of the preparation, cultures were exposed to lipopolysaccharide (LPS, 5 µg/mL for 12 h), which increased nitrite levels and was associated with a higher abundance of amoeboid-like cells and increased Iba1-positive and CD68-positive cell labeling. The culture could also be maintained for prolonged periods in vitro, although its biological interpretation changed over time as non-neuronal cells became more prominent. These findings support the use of this preparation as an accessible mixed primary spinal cord platform for studying glial-associated inflammatory responses in vitro and for future screening of anti-inflammatory compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.